Market Tracker

02/10 7:38am ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.345
Delayed Data
As of Feb 09
 +0.009 / +2.68%
Today’s Change
0.26
Today|||52-Week Range
0.85
-4.96%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.34
Today’s open0.33
Day’s range0.33 - 0.35
Volume83,564
Average volume (3 months)436,871
Market cap$66.3M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...-0.11-4.07%
REPHRecro Pharma Inc-0.46-6.49%
NVLSNivalis Therapeutics...+0.04+0.90%
AKAOAchaogen Inc-0.00-0.15%
Data as of 02/09/2016

Financials

Next reporting dateMarch 15, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer &
Secretary
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts